1059 East Meadow Circle
About Immune-Onc Therapeutics
Immune-Onc Therapeutics (“Immune-Onc”) is a newly established biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The Company is applying the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Founders: Guo Liang Yu and Charlene Liao
6 articles with Immune-Onc Therapeutics
Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California.
BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.
Immune-Onc Therapeutics Announces Partnership With University of Texas To Develop Novel Cancer Immunotherapy
Immune-Onc Therapeutics Announces Licensing And Collaboration With Albert Einstein College of Medicine And Memorial Sloan-Kettering Cancer Center To Develop Novel Cancer Immunotherapy